These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 31167158

  • 1. A validated size exclusion chromatography method coupled with fluorescence detection for rapid quantification of bevacizumab in ophthalmic formulations.
    Jirjees F, Soliman K, Wang Y, Sonawane R, Sheshala R, Jones D, Thakur RRS.
    J Pharm Biomed Anal; 2019 Sep 10; 174():145-150. PubMed ID: 31167158
    [Abstract] [Full Text] [Related]

  • 2. Latanoprost Quantification in Ocular Implants and Tissues: HPLC-Fluorescence vs HPLC-UV.
    Soliman K, Jirjees F, Sonawane R, Sheshala R, Wang Y, Jones D, Singh TRR.
    J Chromatogr Sci; 2021 Jan 01; 59(1):64-70. PubMed ID: 33047781
    [Abstract] [Full Text] [Related]

  • 3. Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin(®) ) in neovascular age-related macular degeneration.
    Bonnin P, Pournaras JA, Lazrak Z, Cohen SY, Legargasson JF, Gaudric A, Levy BI, Massin P.
    Acta Ophthalmol; 2010 Sep 01; 88(6):641-5. PubMed ID: 19563370
    [Abstract] [Full Text] [Related]

  • 4. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A, Stinnett S, Fekrat S.
    Am J Ophthalmol; 2008 Jul 01; 146(1):91-5. PubMed ID: 18455144
    [Abstract] [Full Text] [Related]

  • 5. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE, Kanadani TM, Pereira FB, Nehemy MB.
    Ophthalmology; 2015 Aug 01; 122(8):1569-72. PubMed ID: 26038338
    [Abstract] [Full Text] [Related]

  • 6. A Proximity Extension Assay (PEA)-based method for quantification of bevacizumab.
    Mikačić I, Belužić R, Vugrek O, Plavljanić Đ.
    J Pharmacol Toxicol Methods; 2018 Aug 01; 92():20-23. PubMed ID: 29462667
    [Abstract] [Full Text] [Related]

  • 7. Quality of bevacizumab (Avastin®) repacked in single-use glass vials for intravitreal administration.
    Sugimoto MAA, Toledo VPCP, Cunha MRR, Carregal VM, Jorge R, Leão P, Fialho SL, Silva-Cunha A.
    Arq Bras Oftalmol; 2017 Aug 01; 80(2):108-113. PubMed ID: 28591284
    [Abstract] [Full Text] [Related]

  • 8. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients.
    Parikh R, Ross JS, Sangaralingham LR, Adelman RA, Shah ND, Barkmeier AJ.
    Ophthalmology; 2017 Mar 01; 124(3):352-358. PubMed ID: 27890437
    [Abstract] [Full Text] [Related]

  • 9. HPLC-UV method for simultaneous determination of sparfloxacin and dexamethasone sodium phosphate in eye drops.
    Prakash K, Sireesha KR.
    Pak J Pharm Sci; 2019 May 01; 32(3):1057-1061. PubMed ID: 31278720
    [Abstract] [Full Text] [Related]

  • 10. Ranibizumab (Lucentis) versus Bevacizumab (Avastin) for the Treatment of Age-Related Macular Degeneration: An Economic Disparity of Eye Health.
    Moreno TA, Kim SJ.
    Semin Ophthalmol; 2016 May 01; 31(4):378-84. PubMed ID: 27116030
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.
    Ba J, Peng RS, Xu D, Li YH, Shi H, Wang Q, Yu J.
    Drug Des Devel Ther; 2015 May 01; 9():5397-405. PubMed ID: 26451092
    [Abstract] [Full Text] [Related]

  • 12. Short-term effects of intravitreal bevacizumab (Avastin(®)) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration.
    Toklu Y, Cakmak HB, Raza S, Anayol A, Asik E, Simşek S.
    Acta Ophthalmol; 2011 Feb 01; 89(1):e41-5. PubMed ID: 21232081
    [Abstract] [Full Text] [Related]

  • 13. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial.
    Kodjikian L, Souied EH, Mimoun G, Mauget-Faÿsse M, Behar-Cohen F, Decullier E, Huot L, Aulagner G, GEFAL Study Group.
    Ophthalmology; 2013 Nov 01; 120(11):2300-9. PubMed ID: 23916488
    [Abstract] [Full Text] [Related]

  • 14. Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration.
    Mete A, Saygili O, Mete A, Bayram M, Bekir N.
    J Clin Ultrasound; 2010 Feb 01; 38(2):66-70. PubMed ID: 19953626
    [Abstract] [Full Text] [Related]

  • 15. Quantification and structure elucidation of in vivo bevacizumab modification in rabbit vitreous humor after intravitreal injection.
    Chu KO, Liu DT, Chan KP, Yang YP, Yam GH, Rogers MS, Pang CP.
    Mol Pharm; 2012 Dec 03; 9(12):3422-33. PubMed ID: 23094698
    [Abstract] [Full Text] [Related]

  • 16. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.
    Retina; 2006 Dec 03; 26(5):495-511. PubMed ID: 16770255
    [Abstract] [Full Text] [Related]

  • 17. Simple HPLC determination of benzalkonium chloride in ophthalmic formulations containing antazoline and tetrahydrozoline.
    Rojsitthisak P, Wichitnithad W, Pipitharome O, Sanphanya K, Thanawattanawanich P.
    PDA J Pharm Sci Technol; 2005 Dec 03; 59(5):332-7. PubMed ID: 16316068
    [Abstract] [Full Text] [Related]

  • 18. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.
    Lazic R, Gabric N.
    Graefes Arch Clin Exp Ophthalmol; 2007 Jan 03; 245(1):68-73. PubMed ID: 17111146
    [Abstract] [Full Text] [Related]

  • 19. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR, Kozak I, Yuson RM, Nigam N, Cheng L, Mojana F.
    Retina; 2011 Oct 03; 31(9):1812-8. PubMed ID: 21866073
    [Abstract] [Full Text] [Related]

  • 20. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM, Yoganathan P, Chien FY, Corcóstegui IA, Blumenkranz MS, Deramo VA, Elner SG, Fastenberg DA, Johnson MW, López M, Mateo C, Moshfeghi DM, Navarro R, Rosenblatt BJ, Sanislo SR, Saxe SJ, Zacks DN.
    Retina; 2007 Jun 03; 27(5):535-40. PubMed ID: 17558313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.